Summary of Patient and Tumor Characteristics
| No. of patients | n = 20 |
| Median age (y) | 63 (range, 47–69) |
| Sex | |
| Female | 2 (10) |
| Male | 18 (90) |
| Primary location | |
| Oropharynx | 18 (90) |
| Hypopharynx/larynx | 2 (10) |
| HPV status | |
| Positive | 12 (60) |
| Negative | 8 (40) |
| Grade | |
| G1–2 | 7 (35) |
| G3 | 13 (65) |
| Stage | |
| T | |
| 1–2 | 11 (55) |
| 3–4 | 9 (45) |
| N | |
| 0–1 | 2 (10) |
| 2–3 | 18 (90) |
| IC | |
| Cisplatin/5-fluorouracil | 4 (20) |
| Carboplatin/5-fluorouracil | 5 (25) |
| TPF | 11 (55) |
| Concomitant chemotherapy | |
| Cisplatin | 8 (40) |
| Carboplatin | 8 (40) |
| Cisplatin/carboplatin* | 3 (15) |
| None | 1 (5) |
↵* Cisplatin on day 1 switched to carboplatin on day 29.
TPF = docetaxel/cisplatin/5-fluorouracil.
Data in parentheses are percentages, unless otherwise indicated.